Aprinoia Therapeutics Company

Biotechnology, Neuorscience

Last Funding Type: Series C
Funding Status: Late Stage Venture
Headquarters: Boston, Massachusetts, United States
Founded Date: 2015-05-20
Last Funding Date: 2021-12-28
Total Funding: 57530000.0
Estimated Revenue: $1M to $10M
Investors Number: 8.0
Industry: Neuroimaging